Relationships between plasma amino acid concentrations and blood pressure in South Africans of African descent ever, despite data to suggest that increasing the availability of arginine may reduce cardiovascular risk, there is little evidence to indicate that the availability of arginine as a substrate for NO is in fact abnormal.
INTRODUCTION
Despite considerable advances in treatment, cardiovascular disease remains a leading cause of death worldwide (1) consequently;
improved methods of managing cardiovascular risk are required.
An important change associated with vascular pathology is abnormalities of endothelial function and in this regard, changes in the capacity of endothelial cells to synthesise and release nitric oxide (NO) is a key alteration. Twenty years ago NO was identifi ed as an arterial vasodilator (2, 3) formed from the semi-essential amino acid, L-arginine, in endothelial cells. (4) Although NO production depends on extracellular arginine, (5) the importance of arginine in cardiovascular diseases is derived mainly from studies showing benefi cial effects of supplementation. Indeed, arginine supplementation decreases blood pressure (BP); (6) improves outcomes in patients with heart failure; (7) increases coronary small vessel endothelial function; (8) inhibits atherogenesis; (9, 10) and improves hemodynamic responses in hypercholesterolemic men. (11) How- 
143
Although it is thought that circulating arginine concentrations remain constant, low arginine concentrations do occur (12) and, in infectious diseases, where the inducible form of nitric oxide synthase (iNOS) would be active, these decreased concentrations are associated with adverse outcomes in diseases such as cerebral malaria. (13) With respect to cardiovascular diseases, some studies have assessed the relationship between plasma arginine concentrations and BP with outcomes that suggest that, although the availability of arginine is not reduced in hypertension, the capacity to produce NO from arginine may be impaired. (14) (15) (16) None of these studies were conducted in groups of African ancestry whom have a higher prevalence of hypertension than their Caucasian counterparts. (17) Consequently, the aim of the present study was to evaluate the relationship between plasma arginine or other amino acids and BP in a group of African descent living in Africa. 
METHODS

Study group and BP measurement
Plasma amino acid measurements
After having fasted from 22:00 hours the previous night, early morning blood samples were obtained from participants and plasma was stored at -70 o C. Concentrations of amino acids were determined using high performance liquid chromatography (HPLC)-mass spectrometry (MS) according to previously described techniques. (18, 19) Quantifi cation of the amino acids was performed using an Agelient HPLC system using a Phenomenex Prodigy C18 column (4.6x100mm; 3μm particle size) equilibrated with 25mM
heptafl uorobutyric acid in water containing 5% acetonitrile and 0.1% formic acid (Mobile phase A) at 45 o C. Separation was achieved with a gradient of 25mM heptafl uorobutyric acid in acetonitrile containing 5% water and 0.1% formic acid. The gradient was as follows: 0-3 minutes: 100% A; 3-9.5 minutes: 30% B; 9.5-13.5 minutes: 32% B; 13.5-14 minutes 60% B with a 4 minutes re-equilibration step. A fl ow rate of 700μl/min was used and a 10μl injection volume. Eluting peaks were identifi ed by retention time and multiple reactions monitoring using a MSD Sciex 4000QTrap mass spectrometer in positive mode at 5200V.
Data analysis
Analysis was performed using SAS version 9.1 software. Results are reported as mean±SD or as frequencies. Either a Student's t-test or a Kruskal-Wallis test was used to determine differences between groups for normally and non-normally distributed data respectively. Pearson's correlation coeffi cients were used to determine the association between variables and multivariate regression analysis to assess the independent relationships between plasma arginine concentrations and BP. Primary analysis was conducted in the whole group, but as the majority of participants were male, secondary analysis was performed in males only. As obesity may represent a nutritional abnormality that may alter plasma amino acid profi les, secondary analysis was also conducted in participants with a BMI<30 kg/m 2 . A p-value of less than 0.05 was considered to be of statistical signifi cance. Table 1 shows the characteristics of the participants and the differences in the characteristics of participants with a normal and increased day BP. The majority of participants were male (80%).
RESULTS
Participant characteristics
The mean age of the participants was 49 and approximately one third had a history of regular smoking or use of alcohol. Plasma amino acid profi les in participants Table 2 shows the amino acid profi les in all participants and the differences in amino acid profi les of participants with a normal versus increased day BP. A lower plasma serine concentration was noted in participants with elevated day diastolic BP values. Moreover, an increased plasma arginine concentration was noted in participants with an increased day systolic BP.
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Relationship between plasma amino acid concentrations and ambulatory BP Table 3 shows the Pearson's correlation coeffi cients between plasma arginine and lysine concentrations and ambulatory BP. 
DISCUSSION
The main fi nding of the present study is that plasma concentrations of the NO precursor, L-arginine, are positively associated with night diastolic BP in a group of 75 participants of African descent in Africa and that this association remained after adjustments for potential confounders in addition to the plasma concentrations of other amino acids. This positive association between plasma arginine concentrations and night diastolic BP was similarly observed in secondary analysis in the predominant gender (male) in the study group and in participants whom were not obese. The results of the present study need to be interpreted in the context of the study limitations. In this regard, the present study was conducted in a study sample with a high proportion of men (80%). Hence, the outcomes may refl ect a gender-specifi c effect.
Second, the present study was performed in a convenience sample and hence further studies are required in a larger study sample of randomly recruited participants. Third, the present study was a cross-sectional study and hence further studies are required to establish a temporal relationship between plasma arginine concentrations and ambulatory BP. Last, we did not measure membrane transport of arginine or NO production from cells in participants and hence we could not provide an explanation for the positive relationship between plasma arginine concentrations and BP.
In conclusion, a positive relationship between plasma arginine concentrations and ambulatory BP occurs in people of African origins. These data support the notion (14) (15) (16) that although increases in BP are unlikely to be attributed to a decreased availability of arginine, increases in BP may occur because of a defi ciency in arginine uptake resulting in a reduced synthesis of NO. 
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The results of the present study conducted in a group of African descent in Africa, concur with two studies conducted in Caucasian groups with a case-control study design showing that plasma arginine concentrations are increased in hypertensive patients. (14, 15) In this regard however, in one study, (14) plasma samples were obtained in 36 normotensive controls and 34 hypertensives whilst these patients were still on therapy. Therefore, whether the results of this prior study (14) represent an impact of treatment or the presence of hypertension is uncertain. In the other study, plasma arginine concentrations were shown to be increased in 36 never-treated hypertensives as compared to only 8 control participants. (15) It may be argued that these data refl ect a false positive outcome as the study sample of control participants was very small. The results of the present study therefore add to these prior studies as the analyses performed was conducted using a continuous (regression analysis) together with a case-control approach, the study sample size of never-treated participants (n=75) was considerably larger than prior studies, and ambulatory BP was performed to improve the sensitivity of the analysis.
The positive association between plasma arginine concentrations and BP in the present study requires an explanation. In this regard it is unlikely to refl ect cause and effect as extracellular arginine is required for NO production (5) and consequently vasodilatation (19, 20) a change that will decrease and not increase BP. Moreover, supplementation with dietary arginine decreases BP in hypertension. (6) It is possible that the positive relationship between plasma arginine concentrations and BP may refl ect a reduced capacity for the cellular uptake of arginine as previously suggested, (14, 15) a change which would increase plasma arginine concentrations whilst at the same time reduce the capacity for NO synthesis.
We are unable to provide an explanation for either the lower plasma serine concentrations in participants with an elevated BP or the positive relationship between plasma lysine concentrations and ambulatory BP in males with a BMI <30 kg/m 2 . However, studies conducted in a genetic animal model of hypertension (21) have similarly reported decreased serine concentrations in hypertension. Moreover, plasma lysine concentrations may be closely
